4//SEC Filing
Lowery Thomas J. 4
Accession 0000899243-20-005805
CIK 0001492674other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 6:19 PM ET
Size
9.2 KB
Accession
0000899243-20-005805
Insider Transaction Report
Form 4
Lowery Thomas J.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2020-02-21+10,000→ 74,802 total - Exercise/Conversion
Restricted Stock Units
2020-02-21+10,000→ 20,000 total→ Common Stock (10,000 underlying) - Sale
Common Stock
2020-02-24$0.82/sh−5,808$4,763→ 68,994 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2018.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $0.80 to $0.87. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001615632
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 6:19 PM ET
- Size
- 9.2 KB